found that activated T cell-derived exosomal PD-1 can induce cell surface or exosomal PD-L1 internalization, and thereby restoring tumor surveillance and attenuating PD-L1-induced immune dysfunction in triple-negative breast cancer (Qiu et al., 2021). This evidence concerns the gene CD274 and triple-negative breast carcinoma.